Literature DB >> 16647699

Evaluation of clinical and biochemical parameters in hepatocellular carcinoma: experience from an Indian center.

Nitin Saini1, Ashish Bhagat, Sanjeev Sharma, Ajay Duseja, Yogesh Chawla.   

Abstract

BACKGROUND: Hepatocellular carcinoma (HCC) is the most common primary malignancy of the liver. Several etiologic factors including hepatitis viruses, alcohol and aflatoxin have been implicated in the pathogenesis of HCC. However, there is limited information regarding clinicopathological profile of HCC from the Indian subcontinent.
METHODS: Forty seven patients of HCC (M=43, F=4) diagnosed on the basis of history, clinical examination, imaging (USG, CT/MRI), alpha-fetoprotein (AFP) and by USG/CT guided FNAC, were included. Patients were screened for HBV, HCV and history of alcohol. Tumor size was assessed on imaging and UGI endoscopy for the presence of varices.
RESULTS: The mean age was 53.4+/-14.6 y. Clinical presentation included anorexia in 32 (68%), abdominal pain in 28 (60%), loss of weight in 23 (49%), fever in 12 (26%), and jaundice in 6 (13%) patients. Twenty nine (62%) had underlying cirrhosis, diagnosed by ultrasound or CT. Seventeen percent had normal AFP (<10 ng/ml) and the remaining 83% had raised AFP [<10 ng/ml=7, 10-400 ng/ml=27, >400 ng/ml=8]. Thirteen patients (28%) were consuming alcohol in cirrhogenic doses and 10 (21%) were smokers. Fifty four percent were positive for HBsAg, 47% of these were also positive for HBeAg. Twenty seven percent were positive for anti-HCV. Tumor size on imaging was analyzed in 33 patients. Tumor size varied from <3 cm in 8 (18%), 3-5 cm in 12 (27%) and >5 cm in 25 (56%) patients. Twenty-three patients were lost to follow-up, 4 died and 6 did not agree for any treatment. Only 5 patients could be subjected to hepatic resection. Remaining 9 patients had a large tumor size and were put on tamoxifen.
CONCLUSION: More than half of the HCC cases have underlying cirrhosis. Hepatitis B virus infection is commonly associated. Most of patients have a large tumor (>5 cm) at presentation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16647699     DOI: 10.1016/j.cca.2006.02.038

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  8 in total

1.  Current profile of hepatocellular carcinoma from a tertiary care center in Andhra Pradesh.

Authors:  Jayanthi Srirambhatla; Vijay Gandhi Linga; Krishna Mani Iyer Kalpathi; Joseph Stalin Chowdary; Sadashivudu Gundeti; Raghunadharao Digumarti; Tara Roshni Paul
Journal:  Indian J Gastroenterol       Date:  2015-07

2.  Significance of Glypican-3 in Early Detection of Hepatocellular Carcinoma in Cirrhotic Patients.

Authors:  Ahmed M Tahon; Magdy Z El-Ghanam; Samy Zaky; Tarek Mostafa Emran; Ali M Bersy; Fathiya El-Raey; Elsayed A Z; Amr M El Kharsawy; Dina Johar
Journal:  J Gastrointest Cancer       Date:  2019-09

Review 3.  The Indian National Association for Study of the Liver (INASL) Consensus on Prevention, Diagnosis and Management of Hepatocellular Carcinoma in India: The Puri Recommendations.

Authors:  Ashish Kumar; Subrat K Acharya; Shivaram P Singh; Vivek A Saraswat; Anil Arora; Ajay Duseja; Mahesh K Goenka; Deepali Jain; Premashish Kar; Manoj Kumar; Vinay Kumaran; Kunisshery M Mohandas; Dipanjan Panda; Shashi B Paul; Jeyamani Ramachandran; Hariharan Ramesh; Padaki N Rao; Samir R Shah; Hanish Sharma; Ragesh B Thandassery
Journal:  J Clin Exp Hepatol       Date:  2014-05-22

4.  Experience With Changing Etiology and Nontransplant Curative Treatment Modalities for Hepatocellular Carcinoma in a Real-Life Setting-A Retrospective Descriptive Analysis.

Authors:  Suneel Tohra; Ajay Duseja; Sunil Taneja; Naveen Kalra; Ujjwal Gorsi; Arunanshu Behera; Lileswar Kaman; Divya Dahiya; Srimanta Sahu; Balkrishan Sharma; Virendra Singh; Radha K Dhiman; Yogesh Chawla
Journal:  J Clin Exp Hepatol       Date:  2021-02-11

5.  Profile of hepatocellular carcinoma in a tertiary care hospital in Punjab in northern India.

Authors:  Ajit Sood; Vandana Midha; Omesh Goyal; Prerna Goyal; Neena Sood; Suresh Kumar Sharma
Journal:  Indian J Gastroenterol       Date:  2013-09-06

Review 6.  Current Scenario of Hepatitis B and Its Treatment in India.

Authors:  Gautam Ray
Journal:  J Clin Transl Hepatol       Date:  2017-07-08

7.  Profile of patients with hepatocellular carcinoma: An experience from a tertiary care center in India.

Authors:  Balaji Musunuri; Shiran Shetty; Ganesh Bhat; Karthik Udupa; Ananth Pai
Journal:  Indian J Gastroenterol       Date:  2022-02-28

8.  Viral genotypes and associated risk factors of hepatocellular carcinoma in India.

Authors:  Manash Pratim Sarma; Mohammad Asim; Subhash Medhi; Thayumanavan Bharathi; Richa Diwan; Premashis Kar
Journal:  Cancer Biol Med       Date:  2012-09       Impact factor: 4.248

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.